Medite Cancer Diagnostics (Medite Cancer Diagnostics) EBITDA Margin % : -0.67% (As of Sep. 2018)

Medite Cancer Diagnostics EBITDA Margin % Chart

Medite Cancer Diagnostics Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
EBITDA Margin %		Get a 7-Day Free Trial					5.91	-2.04	-4.27	-15.66	-90.81

Medite Cancer Diagnostics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
EBITDA Margin %	Get a 7-Day Free Trial															-76.81	-136.75	-59.07	2.15	-0.67

Competitive Comparison of Medite Cancer Diagnostics's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Medite Cancer Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medite Cancer Diagnostics's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medite Cancer Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medite Cancer Diagnostics's EBITDA Margin % falls into.

Medite Cancer Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medite Cancer Diagnostics's EBITDA Margin % for the fiscal year that ended in Dec. 2017 is calculated as

Medite Cancer Diagnostics's EBITDA Margin % for the quarter that ended in Sep. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medite Cancer Diagnostics  (OTCPK:MDIT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medite Cancer Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Medite Cancer Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medite Cancer Diagnostics (Medite Cancer Diagnostics) Business Description